$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Suppressor cell function inhibition following Listeria vaccine treatment 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/02
  • A61K-039/00
  • A61K-039/12
  • A61K-035/74
  • A61K-048/00
  • A61K-035/00
출원번호 US-0383970 (2013-03-12)
등록번호 US-10058599 (2018-08-28)
국제출원번호 PCT/US2013/030521 (2013-03-12)
국제공개번호 WO2013/138337 (2013-09-19)
발명자 / 주소
  • Singh, Reshma
  • Wallecha, Anu
출원인 / 주소
  • ADVAXIS, INC.
대리인 / 주소
    Alston & Bird LLP
인용정보 피인용 횟수 : 0  인용 특허 : 89

초록

This invention provides methods and compositions for using a live attenuated Listeria for inhibiting cell-mediated suppression of anti-disease infiltrating T lymphocytes in a subject having the disease.

대표청구항

1. A method of reducing suppression of activated T cells by suppressor cells in an antigen non-specific manner in a subject having asthma or in a disease site within the subject, the method comprising the step of administering to the subject a composition comprising a live attenuated Listeria vaccin

이 특허에 인용된 특허 (89)

  1. Singh, Reshma; Paterson, Yvonne, -based and LLO-based vaccines.
  2. LaPosta Vincent James ; Eldridge John Hayward, Adjuvant and vaccine compositions containing monophosphoryl lipid A.
  3. Paterson, Yvonne; Verch, Thorsten, Antibiotic resistance free strains and methods for constructing and using same.
  4. Paterson, Yvonne; Verch, Thorsten, Antibiotic resistance free vaccines and methods for constructing and using same.
  5. Collins,Mary; Wood,Clive R.; Carreno,Beatriz M.; Luxenberg,Deborah; Jussif,Jason; Carter,Laura L.; Bennett,Frances K.; Valge Archer,Vila; Andrews,John; Russell,Caroline, Antibodies against PD-1.
  6. Carven, Gregory John; van Eenennaam, Hans; Dulos, Gradus Johannes, Antibodies to human programmed death receptor PD-1.
  7. Portnoy, Daniel A.; O'Riordan, Mary; Glomski, Ian, Attenuated and methods for using the same.
  8. Portnoy Daniel A. ; Higgins Darren E., Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells.
  9. Paterson, Yvonne; Gunn, III, George Raymond; Peters, Christian, Composition and methods for enhancing immunogenecity of antigens.
  10. Paterson, Yvonne; Rothman, John; Shahabi, Vafa, Compositions and methods comprising KLK3 of FOLH1 antigen.
  11. Paterson, Yvonne; Rothman, John; Shahabi, Vafa, Compositions and methods comprising KLK3 or FOLH1 antigen.
  12. Carrano Richard A. ; Wang Bin,CNX ; Weiner David B., Compositions and methods for delivery of genetic material.
  13. Paterson, Yvonne; Gunn, III, George Raymond; Peters, Christian, Compositions and methods for enhancing immunogenicity of antigens.
  14. Paterson, Yvonne; Peters, Christian; Gunn, George, Compositions and methods for enhancing the immunogenicity of antigens.
  15. Paterson, Yvonne; Peters, Christian; Gunn, George, Compositions and methods for enhancing the immunogenicity of antigens.
  16. Paterson, Yvonne; Peters, Christian; Gunn, George, Compositions and methods for enhancing the immunogenicity of antigens.
  17. Paterson, Yvonne; Souders, Nicholas; Sewell, Duane; Pan, Zhen-kun; Singh, Reshma, Compositions and methods for enhancing the immunogenicity of antigens.
  18. Shahabi, Vafa; Wallecha, Anu; Maciag, Paulo C.; Paterson, Yvonne; Seavey, Matthew, Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors.
  19. Shahabi, Vafa; Wallecha, Anu; Maciag, Paulo C.; Paterson, Yvonne; Mason, Nicola; Seavey, Matthew, Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors.
  20. Paterson, Yvonne; Rothman, John, Compositions and methods for treatment of cervical cancer.
  21. Paterson, Yvonne; Rothman, John, Compositions and methods for treatment of cervical dysplasia.
  22. Paterson, Yvonne; Neeson, Paul, Compositions and methods for treatment of non-hodgkins lymphoma.
  23. Paterson, Yvonne; Maciag, Paulo; Ferrone, Soldano, Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof.
  24. Paterson, Yvonne; Maciag, Paulo; Seavey, Matthew; Ferrone, Soldano, Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof.
  25. Seavey, Matthew; Paterson, Yvonne; Maciag, Paulo; Sewell, Duane, Compositions comprising angiogenic factors and methods of use thereof.
  26. Seavey, Matthew; Paterson, Yvonne; Maciag, Paulo; Sewell, Duane, Compositions comprising angiogenic factors and methods of use thereof.
  27. Paterson, Yvonne; Peters, Christian, Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector.
  28. Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Delivery of exogenous DNA sequences in a mammal.
  29. Maciag, Paulo; Wallecha, Anu; Shahabi, Vafa, Dual delivery system for heterologous antigens.
  30. Maciag, Paulo; Wallecha, Anu; Shahabi, Vafa, Dual delivery system for heterologous antigens.
  31. Gruenwald Stefan ; Sang Bi-Ching ; Monell Craig, E2A/pbx1 fusion protein specific monoclonal antibodies.
  32. Short, Jay M.; Frey, Gerhard Johann, End selection in directed evolution.
  33. Dubensky, Jr., Thomas W.; Skoble, Justin; Lauer, Peter M.; Cook, David N., Engineered .
  34. Kessick Michael A. (Edmonton CAX) George Zacharia M. (Edmonton CAX) Schneider Linda G. (Edmonton CAX), Formation of coke from heavy crude oils in the presence of calcium carbonate.
  35. Paterson, Yvonne, Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity.
  36. Polack, Axel; Hortnagel, Konstanze; Wolf, Jurgen; Mucke, Susanne, Gene construct and its use.
  37. Cheever,Martin A.; Gheysen,Dirk, HER-2/neu fusion proteins.
  38. Hudziak Robert Michael ; Shepard H. Michael ; Ullrich Axel,DEX, HER2 extracellular domain.
  39. Korman, Alan J.; Srinivasan, Mohan; Wang, Changyu; Selby, Mark J.; Chen, Bingliana; Cardarelli, Josephine M., Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics.
  40. Vasquez Maximiliano ; Landolfi Nicholas F. ; Tsurushita Naoya ; Queen Cary L., Humanized antibodies to .gamma.-interferon.
  41. Karp, Nelson M., Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site.
  42. Karp, Nelson M., Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site.
  43. Frankel Fred R. ; Portnoy Daniel A., Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use.
  44. Yang Yan-ping (Willowdale CAX) Kandil Ali (Willowdale CAX) Gisonni Lucy (Toronto CAX) Fahim Raafat Emil Fahmy (Mississauga CAX) Klein Michel Henri (Willowdale CAX), Immunogenic conjugate molecules.
  45. Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Induction of a protective immune response in a mammal by injecting a DNA sequence.
  46. Lee Kyung-Dall (Providence RI) Portnoy Daniel A. (Philadelphia PA) Swanson Joel A. (Brookline MA), Intracellular delivery of macromolecules.
  47. Mann Michael J. ; Diet Frank P.,DEX ; Dzau Victor J. ; Gibbons Gary H. ; Von Der Leyen Heiko,DEX, Intracellular delivery of nucleic acids using pressure.
  48. Portnoy Daniel A. ; Higgins Darren E., Intracellular delivery vehicles.
  49. Portnoy, Daniel A.; Higgins, Darren E., Intracellular delivery vehicles.
  50. Lurquin Christophe,BEX ; Brasseur Francis,BEX ; Boon-Falleur Thierry,BEX, Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof.
  51. Frankel, Fred R., Isolated nucleic acids comprising Listeria dal and dat genes.
  52. Frankel, Fred R.; Portnoy, Daniel A., Isolated nucleic acids comprising Listeria dal and dat genes.
  53. Dubensky, Jr., Thomas W.; Brockstedt, Dirk G.; Cook, David N., Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof.
  54. Rothman, John; Wallecha, Anu; Singh, Reshma; Harn, Jr., Donald A.; Paterson, Yvonne, Listeria-based adjuvants.
  55. Portnoy Daniel A. ; Paterson Yvonne, Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response.
  56. Sanford John C. (Geneva) DeVit Michael J. (Geneva NY) Bruner Ronald F. (Sewell NJ) Johnston Stephen A. (Durham NC), Method and apparatus for introducing biological substances into living cells.
  57. Frey, II,William H., Method for administering a cytokine to the central nervous system and the lymphatic system.
  58. Powell Robert J. ; Lewis George K. ; Hone David M., Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same.
  59. Wilfried Dalemans BE; Marcelle Van Mechelen BE; Claudine Bruck BE; Martin Friede GB, Method to enhance an immune response of nucleic acid vaccination.
  60. Paterson, Yvonne, Methods and compositions for immunotherapy of cancer.
  61. Paterson, Yvonne; Singh, Reshma, Methods and compositions for immunotherapy of cancer.
  62. Paterson,Yvonne, Methods and compositions for immunotherapy of cancer.
  63. Carson Dennis A. (Del Mar CA) Raz Eyal (San Diego CA), Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleoti.
  64. Carson Dennis A. ; Raz Eyal ; Howell Meredith L., Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptide.
  65. Paterson, Yvonne; Verch, Thorsten, Methods for constructing antibiotic resistance free vaccines.
  66. Paterson, Yvonne; Verch, Thorsten, Methods for constructing antibiotic resistance free vaccines.
  67. Paterson, Yvonne; Verch, Thorsten, Methods for constructing antibiotic resistance free vaccines.
  68. Morsey Mohamad A.,CAX, Methods for production of recombinant plasmids.
  69. Frankel,Fred R.; Portnoy,Daniel A., Methods of inducing immune responses through the administration of auxtrophic attenuated dal/dat double mutant Listeria strains.
  70. Collins, Mary; Wood, Clive R.; Carreno, Beatriz M.; Luxenberg, Deborah; Jussif, Jason; Carter, Laura L.; Bennett, Frances K.; Valge Archer, Viia; Andrews, John; Russell, Caroline, Methods of upmodulating adaptive immune response using anti-PD-1 antibodies.
  71. Paterson, Yvonne; MaCiag, Paulo, Non-hemolytic LLO fusion proteins and methods of utilizing same.
  72. Paterson, Yvonne; Maciag, Paulo Cesar, Non-hemolytic LLO fusion proteins and methods of utilizing same.
  73. Jay M. Short, Non-stochastic generation of genetic vaccines.
  74. Savitzky, Kinneret; Mintz, Liat; David, Anat; Azar, Idit, Nucleic acid and amino acid sequences.
  75. Korman, Alan J.; Selby, Mark J.; Wang, Changyu; Srinivasan, Mohan; Passmore, David B.; Huang, Haichun; Chen, Haibin, Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1).
  76. Andersen, Peter; Nielsen, Rikke; Oettinger, Thomas; Rasmussen, Peter Birk; Rosenkrands, Ida; Weldingh, Karin; Florio, Walter, Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis.
  77. Finnefrock, Adam C.; Fu, Tong-Ming; Freed, Daniel C.; Casimiro, Danilo R.; Li, Fengsheng; Tang, Aimin, PD-1 binding proteins.
  78. Ferrone, Soldano; Chang, Chien-Chung; Luo, Wei; Wang, Xinhui; Ghosh, Debashis, Peptides for stimulating an immune response against melanoma.
  79. Content Jean,BEX ; Huygen Kris,BEX ; Liu Margaret A. ; Montgomery Donna ; Ulmer Jeffrey, Polynucleotide tuberculosis vaccine.
  80. Caruthers Marvin H. (Boulder CO) Matteucci Mark D. (Boulder CO), Process for preparing polynucleotides.
  81. Curtiss, III, Roy; Tinge, Steven A., Recombinant bacterial vaccine system with environmentally limited viability.
  82. Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
  83. Dubensky, Jr., Thomas W.; Portnoy, Daniel A.; Luckett, Jr., William S.; Cook, David N., Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof.
  84. Brown Joseph P. (Seattle WA) Estin Charles D. (Bainbridge Island WA) Plowman Gregory D. (Seattle WA) Rose Timothy M. (Seattle WA) Hellstrom Karl E. (Seattle WA) Hellstrom Ingegerd (Seattle WA) Purchi, Recombinant viruses encoding the human melanoma-associated antigen.
  85. Branstrom Arthur A. ; Sizemore Donata R. ; Sadoff Jerald C., Shigella vector for delivering DNA to a mammalian cell.
  86. Portnoy,Daniel A.; Calendar,Richard; Lauer,Peter M., Site specificintegration vectors and methods for using the same.
  87. Paterson Yvonne, Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector.
  88. Harn, Jr., Donald A.; Paterson, Yvonne; McEwen, Lisa, Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals.
  89. Dubensky, Jr., Thomas W.; Brockstedt, Dirk G.; Cook, David N., attenuated for entry into non-phagocytic cells, vaccines comprising the , and methods of use thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로